Fairbairn Robert W's Form 4 filing
BlackRock Health Sciences Term Trust (BMEZ) · filed Dec 22, 2025
- Accession no.
- 0001193125-25-329003
- Filed
- Dec 22, 2025
- Trade date
- Dec 18-19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $308.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fairbairn Robert WCIK 0001376962 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Common Stock | SSaleDisposed | −10,294 | $14.98 | −$154,204.12 | 0.42 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −0.42 | $14.96 | −$6.28 | 0 | Direct | |
| Dec 18, 2025 | Common Stock | SSaleDisposed | −10,294 | $14.98 | −$154,204.12 | 0.42 | Indirect | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −0.42 | $14.96 | −$6.28 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.